<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02500277</url>
  </required_header>
  <id_info>
    <org_study_id>NK/1815/Res/2439</org_study_id>
    <nct_id>NCT02500277</nct_id>
  </id_info>
  <brief_title>Yield of Cryoprobe vs Flexible Forceps Pleural Biopsy</brief_title>
  <acronym>COFFEE</acronym>
  <official_title>A Study to Evaluate the Yield of Pleural Biopsy With a Flexible Cryoprobe Versus Flexible Forceps During Semirigid Thoracoscopy: a Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Postgraduate Institute of Medical Education and Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study to assess the yield of pleural biopsy obtained with the routine
      flexible thoracoscopic biopsy forceps versus that obtained with a flexible cryoprobe during
      semirigid thoracoscopy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive patients with exudative pleural effusions who are planned to undergo semirigid
      thoracoscopy will be enrolled in the study if they satisfy the inclusion criteria. They will
      be randomized in 1:1 ratio using a computer-generated randomization sequence to the following
      groups:

      Group A: Four pleural biopsy specimens obtained using the flexible cryoprobe followed by
      eight pleural biopsy specimens obtained using the flexible thoracoscopic forceps OR Group B:
      The above two procedures will be performed in the reverse order The biopsies will be
      performed from different areas of the involved pleura with the two techniques. Thoracoscopy
      will be performed in the bronchoscopy suite on spontaneously breathing subjects (fasting for
      8 h) under conscious sedation (using midazolam, pentazocine, and tramadol) observing complete
      aseptic precautions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Yield of pleural biopsy obtained with the routine flexible thoracoscopic biopsy forceps versus that obtained with a flexible cryoprobe during semirigid thoracoscopy</measure>
    <time_frame>One week</time_frame>
    <description>The proportion of patients where a definitive histopathological diagnosis was obtained will be compared between the cryoprobe and flexible forceps biopsy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biopsy size</measure>
    <time_frame>One day</time_frame>
    <description>Size of biopsy specimens obtained with the two techniques</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of procedure</measure>
    <time_frame>One day</time_frame>
    <description>Time taken for the procedure with the two techniques</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of biopsy VAS</measure>
    <time_frame>One day</time_frame>
    <description>Ease of taking biopsy with the two techniques assessed using a visual analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Artifacts</measure>
    <time_frame>One day</time_frame>
    <description>Number of patient speciemens with histopathologic artifacts with either technique including crush artefacts with the flexible forceps and freeze artifacts with the cryoprobe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue depth</measure>
    <time_frame>One day</time_frame>
    <description>Depth of the tissue obtained on histopathology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>One day</time_frame>
    <description>Number of participants with bleeding seen while taking biopsy categorised into &quot;no bleeding&quot;, &quot;minimal self limited ooze&quot;, &quot;bleeding requiring prolonged suctioning&quot; , &quot;major hemorrhage requiring blood transfusion, causing hemodynamic instability or ICU admission&quot;</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pleural Effusion</condition>
  <condition>Pleurisy</condition>
  <condition>Tuberculosis</condition>
  <condition>Metastatic Malignancy</condition>
  <arm_group>
    <arm_group_label>Cryobiopsy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pleural biopsy with a flexible cryoprobe</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Forceps biopsy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pleural biopsy with a flexible forceps</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryoprobe pleural biopsy first</intervention_name>
    <description>Four pleural biopsy specimens will be obtained using the flexible cryoprobe (ERBOCRYOCA, ERBE, Tubingen, Germany; outer diameter 1.9 mm, length 900 mm) followed by 6-10 pleural biopsy specimens obtained using the flexible thoracoscopic forceps (FB-55CR, Olympus Medical Systems, 2 mm diameter).</description>
    <arm_group_label>Cryobiopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Flexible forceps biopsy first</intervention_name>
    <description>Six to ten pleural biopsy specimens will be obtained using the flexible thoracoscopic forceps (FB-55CR, Olympus Medical Systems, 2 mm diameter) followed by four pleural biopsy specimens obtained using the flexible cryoprobe (ERBOCRYOCA, ERBE, Tubingen, Germany; outer diameter 1.9 mm, length 900 mm)</description>
    <arm_group_label>Forceps biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥12 years

          -  Semirigid thoracoscopy being performed for diagnosis of the pleural effusion

        Exclusion Criteria:

          -  Age ≥80 years

          -  SpO2 &lt;88% on room air

          -  Hemodynamic instability

          -  Myocardial infarction or unstable angina in the last 6 wk

          -  Lack of pleural space due to adhesions

          -  Uncorrected coagulopathy

          -  Failure to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sahajal Dhooria, DM</last_name>
    <phone>+91 172 2756825</phone>
    <email>sahajal@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ritesh Agarwal, DM</last_name>
    <phone>+91 172 2756825</phone>
    <email>riteshpgi@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>PGIMER</name>
      <address>
        <city>Chandigarh</city>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashutosh N Aggarwal, DM</last_name>
      <phone>+91 172 2756824</phone>
      <email>aggarwal.ashutosh@outlook.com</email>
    </contact>
    <contact_backup>
      <last_name>Digambar Behera, MD</last_name>
      <phone>+91 172 2756822</phone>
      <email>dirlrsi@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2015</study_first_submitted>
  <study_first_submitted_qc>July 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2015</study_first_posted>
  <last_update_submitted>February 17, 2018</last_update_submitted>
  <last_update_submitted_qc>February 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Postgraduate Institute of Medical Education and Research</investigator_affiliation>
    <investigator_full_name>Sahajal Dhooria</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>thoracoscopy</keyword>
  <keyword>pleuroscopy</keyword>
  <keyword>semirigid thoracoscopy</keyword>
  <keyword>flexible cryoprobe</keyword>
  <keyword>cryobiopsy</keyword>
  <keyword>pleural biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Pleural Effusion</mesh_term>
    <mesh_term>Pleurisy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

